Lantheus Holdings, Inc. Operating Lease Cost
Lantheus Holdings, Inc. (LNTH) reported Operating Lease Cost of $6.14 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-02-26
- Lantheus Holdings, Inc. operating lease, cost for the quarter ending 2019-12-31 was $56.00K.
- Lantheus Holdings, Inc. operating lease, cost for the quarter ending 2019-09-30 was $55.00K.
- Lantheus Holdings, Inc. operating lease, cost for the quarter ending 2019-06-30 was $56.00K.
- Lantheus Holdings, Inc. operating lease, cost for the quarter ending 2019-03-31 was $56.00K.
- Lantheus Holdings, Inc. operating lease, cost for fiscal 2025 was $6.14M, a 3.96% decline from fiscal 2024.
- Lantheus Holdings, Inc. operating lease, cost for fiscal 2024 was $6.39M, a 38.12% increase from fiscal 2023.
- Lantheus Holdings, Inc. operating lease, cost for fiscal 2023 was $4.63M, a 157.48% increase from fiscal 2022.
- Lantheus Holdings, Inc. operating lease, cost for fiscal 2022 was $1.80M, a 22.28% decline from fiscal 2021.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $6.14M 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $6.39M 10-K · filed 2026-02-26 | |||
| 2023-12-31 | $4.63M 10-K · filed 2026-02-26 | |||
| 2022-12-31 | $1.80M 10-K · filed 2024-02-22 | |||
| 2021-12-31 | $2.31M 10-K · filed 2023-02-23 | |||
| 2020-12-31 | $1.47M 10-K · filed 2022-02-24 | |||
| 2019-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $111.00K derived: sum of 2 quarters · filed 2021-02-25 | $167.00K derived: sum of 3 quarters · filed 2021-02-25 | $223.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $55.00K 10-Q · filed 2019-10-31 | $111.00K derived: sum of 2 quarters · filed 2019-10-31 | $167.00K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $56.00K 10-Q · filed 2019-07-25 | $112.00K 10-Q · filed 2019-07-25 | ||
| 2019-03-31 | $56.00K 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |